Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CXSL2200241	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2022-06-03		view
CYSB2200226	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2022-09-15	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
CXSL2400082	德谷胰岛素利拉鲁肽注射液	insulin degludec;liraglutide	Injection	Biological Products(3.3)	New Drug Application	2024-02-01		view
CXSL2200317	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2022-07-14	Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd	view
CXSL2101500	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2021-12-22	Zhuhai GENE-BIOCON Biological Technology Co Ltd	view
CXSL2300092	德谷胰岛素利拉鲁肽注射液	insulin degludec;liraglutide	Injection	Biological Products(3.3)	New Drug Application	2023-02-08	Federal Biotechnology (Zhuhai Hengqin) Co Ltd	view
JYSZ2200009	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	License Renew	2022-03-04		view
CXSL2400436	德谷胰岛素利拉鲁肽注射液	insulin degludec;liraglutide	Injection	Biological Products(3.3)	New Drug Application	2024-07-09	Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd	view
CYSB2101172	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-08-31	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
CYSB2200227	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2022-09-15	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
JYSB2400021	德谷胰岛素利拉鲁肽注射液	insulin degludec;liraglutide	Injection	Biological Products	Supplementary Application	2024-02-01		view
JYSB2101153	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-10-22	Novo Nordisk A/S	view
CXSL2200458	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2022-09-14	Wanbang Biopharmaceuticals	view
CYSB2300007	德谷胰岛素利拉鲁肽注射液	insulin degludec;liraglutide	Injection	Biological Products	Supplementary Application	2023-01-11	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
JTS2100532	德谷胰岛素二级标准品	insulin degludec	Other	Biological Products	Disposable Import Drug Application	2021-10-14		view
CXSL2400293	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2024-05-09	Shandong New Time Pharmaceutical Co Ltd	view
JYSZ2200008	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	License Renew	2022-03-04		view
CXSL2300515	德谷胰岛素利拉鲁肽注射液	insulin degludec;liraglutide	Injection	Biological Products(3.3)	New Drug Application	2023-07-26	Jilin Huisheng Biopharmaceutical Co Ltd	view
JYSB2101166	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-11-10	Novo Nordisk A/S	view
JYSB2200187	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2022-09-29	Novo Nordisk A/S	view